February 20, 2015 : Episode 1

Video

Lenvatinib and Lenalidomide Approved, New Agent Promising in Myeloma, and More

Related Videos
 Philip McCarthy, MD
Lova L. Sun, MD, MSCE
Robert M. Rifkin, MD, FACP
Emrullah Yilmaz, MD, PhD
Kedar Kirtane, MD
Malcolm Mattes, MD, associate professor, Section of Radiation Oncology, Rutgers Robert Wood Johnson Medical School; radiation oncologist, Rutgers Cancer Institute of New Jersey
Noa Biran, MD
María-Victoria Mateos, MD, PhD
Noopur S. Raje, MD
Suzanne Trudel, MSc, MD